Quest Diagnostics Total Liabilities 2012-2025 | DGX
Quest Diagnostics total liabilities from 2012 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
- Quest Diagnostics total liabilities for the quarter ending December 31, 2025 were $8.902B, a 3.8% decline year-over-year.
- Quest Diagnostics total liabilities for 2024 were $9.34B, a 21.61% increase from 2023.
- Quest Diagnostics total liabilities for 2023 were $7.68B, a 11.19% increase from 2022.
- Quest Diagnostics total liabilities for 2022 were $6.907B, a 3.1% decline from 2021.
|
Quest Diagnostics Annual Total Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $9,340 |
| 2023 | $7,680 |
| 2022 | $6,907 |
| 2021 | $7,128 |
| 2020 | $7,217 |
| 2019 | $7,156 |
| 2018 | $5,736 |
| 2017 | $5,548 |
| 2016 | $5,440 |
| 2015 | $5,249 |
| 2014 | $5,527 |
| 2013 | $4,975 |
| 2012 | $5,098 |
| 2011 | $5,598 |
|
Quest Diagnostics Quarterly Total Liabilities (Millions of US $) |
|
|---|---|
| 2025-09-30 | $8,902 |
| 2025-06-30 | $8,704 |
| 2025-03-31 | $8,835 |
| 2024-12-31 | $9,340 |
| 2024-09-30 | $9,254 |
| 2024-06-30 | $7,225 |
| 2024-03-31 | $7,485 |
| 2023-12-31 | $7,680 |
| 2023-09-30 | $7,019 |
| 2023-06-30 | $7,138 |
| 2023-03-31 | $6,706 |
| 2022-12-31 | $6,907 |
| 2022-09-30 | $6,951 |
| 2022-06-30 | $6,862 |
| 2022-03-31 | $7,027 |
| 2021-12-31 | $7,128 |
| 2021-09-30 | $7,140 |
| 2021-06-30 | $6,921 |
| 2021-03-31 | $7,141 |
| 2020-12-31 | $7,217 |
| 2020-09-30 | $7,697 |
| 2020-06-30 | $7,109 |
| 2020-03-31 | $6,346 |
| 2019-12-31 | $7,156 |
| 2019-09-30 | $6,365 |
| 2019-06-30 | $6,251 |
| 2019-03-31 | $6,596 |
| 2018-12-31 | $5,736 |
| 2018-09-30 | $5,621 |
| 2018-06-30 | $5,484 |
| 2018-03-31 | $5,629 |
| 2017-12-31 | $5,548 |
| 2017-09-30 | $5,611 |
| 2017-06-30 | $5,438 |
| 2017-03-31 | $5,446 |
| 2016-12-31 | $5,440 |
| 2016-09-30 | $5,479 |
| 2016-06-30 | $5,540 |
| 2016-03-31 | $5,431 |
| 2015-12-31 | $5,249 |
| 2015-09-30 | $5,453 |
| 2015-06-30 | $5,376 |
| 2015-03-31 | $6,342 |
| 2014-12-31 | $5,527 |
| 2014-09-30 | $5,591 |
| 2014-06-30 | $5,638 |
| 2014-03-31 | $5,530 |
| 2013-12-31 | $4,975 |
| 2013-09-30 | $5,056 |
| 2013-06-30 | $5,098 |
| 2013-03-31 | $5,079 |
| 2012-12-31 | $5,098 |
| 2012-09-30 | $5,121 |
| 2012-06-30 | $5,372 |
| 2012-03-31 | $5,555 |
| 2011-12-31 | $5,598 |
| 2011-09-30 | $5,782 |
| 2011-06-30 | $5,981 |
| 2011-03-31 | $5,987 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $23.013B | $11.035B |
| Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $34.042B | 17.17 |
| Elanco Animal Health (ELAN) | United States | $12.486B | 26.18 |
| Encompass Health (EHC) | United States | $11.082B | 20.17 |
| DaVita (DVA) | United States | $9.950B | 13.72 |
| Chemed (CHE) | United States | $6.703B | 23.54 |
| Option Care Health (OPCH) | United States | $5.622B | 23.93 |
| RadNet (RDNT) | United States | $5.365B | 183.00 |
| LifeStance Health (LFST) | United States | $2.735B | 0.00 |
| Addus HomeCare (ADUS) | United States | $2.103B | 21.72 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.657B | 20.87 |
| U.S Physical Therapy (USPH) | United States | $1.322B | 33.44 |
| Pennant (PNTG) | United States | $1.106B | 36.75 |
| Astrana Health (ASTH) | United States | $1.057B | 98.84 |
| Daxor (DXR) | United States | $0.062B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.038B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |